Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

479
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
479
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

431
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
431
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

680
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
680
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An artificial intelligence model to detect abnormal ejection fraction from non-contrast chest computed tomography: the CT-LVEF study.

European heart journal. Digital health·2026
Same author

The novelty of anticoagulation in LVAD Therapy: Current Practice, the Role of Direct Oral Anticoagulants, and Future Directions.

Journal of cardiovascular pharmacology·2026
Same author

A Two-Threshold dd-cfDNA Algorithm Improves Detection of Molecular Rejection in Heart Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

De Novo Aortic Insufficiency and Its Progression in Patients on Microaxial Flow Pump Support Before Durable Left Ventricular Assist Device.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

The Pendulum Swings: Reconsidering Durable Left Ventricular Assist Devices as a Bridge to Transplantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Comparative review of coronary CT angiography versus conventional catheter angiography: diagnostic value, clinical outcomes, and underlying technical principles.

Expert review of medical devices·2026
Same journal

Assessing the MYNX CONTROL arterial vascular closure device after catheterization procedures that enter the body through the femoral arteries.

Expert review of medical devices·2026
Same journal

Efficacy of two anatomically preformed supraglottic devices, the BlockBuster Laryngeal mask airway and the Ambu AuraGain, for ventilation in anesthetised paralyzed pediatric patients: a randomized trial.

Expert review of medical devices·2026
Same journal

Prismatic treatment combined with binocular visual training for intermittent exotropia: impact on visual function and quality of life.

Expert review of medical devices·2026
Same journal

Methodological concerns in the comparative evaluation of PORTs and PICCs: limitations of indirect evidence synthesis in a recent meta-analysis.

Expert review of medical devices·2026
Same journal

Response to: 'methodological concerns in the comparative evaluation of PORTs and PICCs: limitations of indirect evidence synthesis in a recent meta-analysis'.

Expert review of medical devices·2026
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Mechanical circulatory support devices: methods to optimize hemodynamics during use.

Ben Bow Chung1, Gabriel Sayer1, Nir Uriel1

  • 1a Section of Cardiology , University of Chicago , Chicago , IL , USA.

Expert Review of Medical Devices
|April 28, 2017
PubMed
Summary
This summary is machine-generated.

Mechanical circulatory support (MCS) improves advanced heart failure management. Optimizing MCS device hemodynamics, particularly with ramp studies, is crucial for patient outcomes.

Keywords:
Left ventricular assist device (LVAD)advanced heart failurehemodynamicsmechanical circulatory supportoptimizationpulmonary capillary wedge pressureramp study

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

25.3K

Related Experiment Videos

Last Updated: Mar 3, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

25.3K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Heart Failure Management

Background:

  • Mechanical circulatory support (MCS) is vital for advanced heart failure, serving as bridge-to-transplant and destination therapy.
  • Understanding the complex hemodynamics of MCS devices is increasingly important due to their prevalence.

Purpose of the Study:

  • To review normal and failing heart hemodynamics.
  • To discuss short-term MCS devices and their hemodynamic effects.
  • To explore left ventricular assist device (LVAD) differences and optimization strategies.

Main Methods:

  • Overview of human heart hemodynamics.
  • Analysis of short-term MCS device hemodynamics.
  • Comparison of different LVAD types and their hemodynamic impacts.
  • Description of hemodynamic optimization techniques using echocardiography and invasive ramp studies.

Main Results:

  • The review covers hemodynamic principles in normal and failing hearts.
  • It details hemodynamic consequences of various short-term MCS devices.
  • Differences in LVADs and their specific hemodynamic effects are discussed.
  • Strategies for hemodynamic optimization, including ramp studies, are presented.

Conclusions:

  • A deeper understanding of MCS device hemodynamics is advocated.
  • Widespread adoption of ramp studies for speed optimization is recommended.
  • These studies are validated across various LVAD types for improved patient management.